1 min read

ID: 678870

Short Link: https://gregory-ms.com/articles/678870/

Discovery Date: 11 July 2022, 05:55:07 UTC

Published Date: 2022-07-10 10:00:00

Source: PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/35810718/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=10guX6I3SqrbUeeLKSTD6FCRM44ewnrN2MKKTQLLPMHB4xNsZU&fc=20210216052009&ff=20220711015506&v=2.17.7

Manual Selection: none

Machine Learning Gaussian Naive Bayes Model: true

Abstract

CONCLUSIONS: The recommendations of clinical neurologists seek to optimize the management of PwMS who may benefit from treatment with natalizumab.

Noun Phrases in Title

  • Use
  • natalizumab
  • persons
  • multiple sclerosis
This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.